MYGN · Myriad Genetics Inc

$5.03 -0.29 (-5.45%)

Market Cap

$502.46M

94.45M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$200,000,000

as of 2017-06-30 · not restated in filings since 2020-11-09

Remaining Authorization

$110,700,000

as of 2023-09-30 · not restated in filings since 2023-11-07

Program Utilization

44.6% $89,300,000 used of $200,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2021-12-31	$0	0	—	10-K, filed 2022-02-25
2020-06-30	$0	0	—	10-K, filed 2022-02-25
2019-06-30	$50,000,000	1,600,000	—	10-K, filed 2022-02-25
2018-06-30	$0	0	—	Other, filed 2021-03-16
2017-06-30	$31,600,000	1,600,000	—	10-K, filed 2019-08-13
2016-06-30	$162,600,000	4,500,000	—	10-K, filed 2018-08-24
2015-06-30	$210,700,000	6,000,000	—	10-K, filed 2017-08-09
2014-06-30	$287,700,000	10,400,000	—	10-K, filed 2016-08-10
2013-06-30	$146,300,000	5,600,000	—	10-K, filed 2015-08-12
2012-06-30	$128,467,000	5,688,000	—	10-K, filed 2014-08-13
2011-06-30	$200,490,000	9,824,000	—	10-K, filed 2013-08-14
2010-06-30	$71,393,000	3,940,000	—	10-K, filed 2012-08-15

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2019-06-30	$0 Δ	—	—	10-K, filed 2022-02-25
2019-03-31	$0 Δ	—	—	10-Q, filed 2020-05-06
2017-06-30	$0 Δ	—	—	10-K, filed 2019-08-13
2017-03-31	$0 Δ	—	—	10-Q, filed 2018-05-09
2016-12-31	$10,300,000 Δ	—	—	10-Q, filed 2018-02-07
2016-09-30	$21,300,000	1,000,000	—	10-Q, filed 2017-11-08
2016-06-30	$54,700,000 Δ	—	—	10-K, filed 2018-08-24
2016-03-31	$45,000,000 Δ	—	—	10-Q, filed 2017-05-03
2015-12-31	$24,900,000 Δ	—	—	10-Q, filed 2017-02-08
2015-09-30	$38,000,000	1,100,000	—	10-Q, filed 2016-11-02
2015-06-30	$44,800,000 Δ	—	—	10-K, filed 2017-08-09
2015-03-31	$62,000,000 Δ	—	—	10-Q, filed 2016-05-04

Key facts CIK 899923 CUSIP 62855J104 13F (30d) 29 filings 29 filers Visit website Investor relations